With CRO consolidation in full swing, Catalent inks a $950M deal to acquire Cook Pharmica and signals an appetite for more
Today it is Catalent’s turn to take a lead role in the consolidation of the global outsourcing business.
The big and growing CMO has snapped up Bloomington, IN-based Cook Pharmica for $950 million, adding a group with 750 staffers involved in biologics development and biomanufacturing and fleshing out the start-to-finish suite of services that Catalent has on offer to the biopharma world.
Cook is bringing their 875,000 square foot facility in Bloomington to the Catalent organization, along with annual revenue of $179 million.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.